S. Carlson

Implications for sequencing of biologic therapy and choice of second anti‐TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti‐TNF therapy (IMSAT) therapeutic drug monitoring study

Thomas M. Riley, C. Lees, T. Ahmad, 2022, Alimentary pharmacology & therapeutics.

Recent advances in the detection and management of early gastric cancer and its precursors

E. Kuipers, M. Jansen, W. Waddingham, 2020, Frontline Gastroenterology.